DVA 241018 140.00P (DVA241018P140000) Stock Options, News & Quotes

US OptionsDetailed Quotes

DVA241018P140000

Watchlist

0.19
-0.11-36.67%

15min DelayClose Oct 4 15:59 ET

0.19High0.19Low

Intraday

5D
Daily

News

Dialysis Services Focused Insights Report 2024-2029 Featuring Key Vendors - B. Braun, Baxter, DaVita, Dialysis Clinic (DCI), Fresenius Medical Care, Innovative Renal Care, and NephroPlus - ResearchAndMarkets.com
BusinesswireOct 2 09:39 ET
Investing in DaVita (NYSE:DVA) Five Years Ago Would Have Delivered You a 193% Gain
Simply Wall StSep 30 11:59 ET
Is DaVita Inc.'s (NYSE:DVA) ROE Of 47% Impressive?
Yahoo FinanceSep 30 11:20 ET
Should Value Investors Buy DaVita (DVA) Stock?
Zacks Sep 27 08:45 ET
Is DaVita Stock Outperforming the Dow?
BarchartSep 27 07:59 ET
Why DaVita HealthCare (DVA) Is a Top Momentum Stock for the Long-Term
Yahoo FinanceSep 24 09:50 ET

Comments

Brianjh

May 29 05:53

Warren Buffett's Current Portfolio

1) $Apple (AAPL.US)$
2) $Bank of America (BAC.US)$
3) $American Express (AXP.US)$
4) $Coca-Cola (KO.US)$
5) $Occidental Petroleum (OXY.US)$
6) $The Kraft Heinz (KHC.US)$
7) $Chevron (CVX.US)$
8) $Moody's (MCO.US)$
9) $Chubb Ltd (CB.US)$
10) $DaVita (DVA.US)$
11) $MITSUBISHI MOTOR CORP (MMTOF.US)$
12) $Mitsui (8031.JP)$
13) $ITOCHU (8001.JP)$

Weekly Buzz

CatM

May 24 16:24

Win

Let’s get ‘em

Share Your Profit/Loss

Moomoo AI

Mar 5 08:01

DaVita's global expansion strategy, backed by strong local team investment, is set to make a lasting impact on healthcare communities. Their focus remains on providing exceptional care for kidney disease patients.

Press Release: DaVita Enters Into Agreement to Expand Operations in Brazil and Colombia, Enter Chile and Ecuador

Brianjh

Feb 16 21:59

Warren Buffet Portfolio

Legendary INvestor Warrent BUffett Portfolio
$Apple (AAPL.US)$ $Bank of America (BAC.US)$ $American Express (AXP.US)$ $Coca-Cola (KO.US)$ $CHERVON (02285.HK)$ $The Kraft Heinz (KHC.US)$ $Moody's (MCO.US)$ $DaVita (DVA.US)$ $CITIC BANK (00998.HK)$

Weekly Buzz

Moomoo AI

Feb 14 10:49

Analysts believe DaVita's strong Q4 financials and full-year outlook were driven by expected volume improvements and continued strong cost controls. However, some analysts maintain a cautious stance, waiting to see more proof points on volume improvement.

DaVita Stock Is Having Its Best Day in Years. Volumes Are Improving After Covid-19. -- Barrons.com